Literature DB >> 8874917

The anaesthetic management of a patient with Emery-Dreifuss muscular dystrophy.

V Jensen1.   

Abstract

PURPOSE: This case report presents a patient with Emery-Dreifuss Muscular Dystrophy and describes the anaesthetic considerations. CLINICAL FEATURES: The features of Emery-Dreifuss Muscular Dystrophy are contractures, humeroperoneal muscle weakness and cardiomyopathy. The anaesthetic considerations for this syndrome are difficult tracheal intubation, difficult spinal anaesthetic, heart block, gastric reflux, rhabdomyolysis, and unproved malignant hyperthermia susceptibility.
CONCLUSION: The major anaesthetic problem for the patient with Emery-Dreifuss Muscular Dystrophy could be a life-threatening cardiomyopathy.

Entities:  

Mesh:

Year:  1996        PMID: 8874917     DOI: 10.1007/BF03011813

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  19 in total

1.  Orthopedic deformities in Emery-Dreifuss muscular dystrophy.

Authors:  F Shapiro; L Specht
Journal:  J Pediatr Orthop       Date:  1991 May-Jun       Impact factor: 2.324

Review 2.  Current status of Duchenne muscular dystrophy.

Authors:  S T Iannaccone
Journal:  Pediatr Clin North Am       Date:  1992-08       Impact factor: 3.278

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 34-1992. A 19-year-old man with progressive proximal muscle weakness, contractures, and cardiac abnormalities.

Authors: 
Journal:  N Engl J Med       Date:  1992-08-20       Impact factor: 91.245

Review 4.  Drug- and toxin-induced rhabdomyolysis.

Authors:  S C Curry; D Chang; D Connor
Journal:  Ann Emerg Med       Date:  1989-10       Impact factor: 5.721

Review 5.  Malignant hyperthermia: relationship to other diseases.

Authors:  A K Brownell
Journal:  Br J Anaesth       Date:  1988-02       Impact factor: 9.166

Review 6.  Rhabdomyolysis in childhood. A primer on normal muscle function and selected metabolic myopathies characterized by disordered energy production.

Authors:  R A Brumback; D L Feeback; R W Leech
Journal:  Pediatr Clin North Am       Date:  1992-08       Impact factor: 3.278

7.  Emery-Dreifuss muscular dystrophy.

Authors:  R P Dickey; F A Ziter; R A Smith
Journal:  J Pediatr       Date:  1984-04       Impact factor: 4.406

8.  Upper gastrointestinal tract motility in children with progressive muscular dystrophy.

Authors:  A Staiano; E Del Giudice; A Romano; M R Andreotti; L Santoro; G Marsullo; P G Rippa; A Iovine; M Salvatore
Journal:  J Pediatr       Date:  1992-11       Impact factor: 4.406

9.  Emery-Dreifuss muscular dystrophy.

Authors:  P Morrison; R H Jago
Journal:  Anaesthesia       Date:  1991-01       Impact factor: 6.955

10.  Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy.

Authors:  S Bione; E Maestrini; S Rivella; M Mancini; S Regis; G Romeo; D Toniolo
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

View more
  1 in total

1.  In vitro contracture test results and anaesthetic management of a patient with emery-dreifuss muscular dystrophy for cardiac transplantation.

Authors:  Frank Schuster; Carsten Wessig; Christoph Schimmer; Stephan Johannsen; Marc Lazarus; Ivan Aleksic; Rainer Leyh; Norbert Roewer
Journal:  Case Rep Anesthesiol       Date:  2012-09-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.